Evidence map›Paper›PMID 38940163›Full record

ArticleBioinformatics (Oxford, England)2024

PhiHER2: phenotype-informed weakly supervised model for HER2 status prediction from pathological images.

Chaoyang Yan, Jialiang Sun, Yiming Guan, Jiuxin Feng, Hong Liu, Jian Liu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chaoyang YanCollege of Computer Science, Nankai University, Tianjin 300071, China.
Jialiang SunCollege of Computer Science, Nankai University, Tianjin 300071, China.
Yiming GuanCollege of Computer Science, Nankai University, Tianjin 300071, China.
Jiuxin FengCollege of Computer Science, Nankai University, Tianjin 300071, China.
Hong LiuThe Second Surgical Department of Breast Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Jian LiuCollege of Computer Science, Nankai University, Tianjin 300071, China.ORCID 0000-0001-5516-0157

Funding

National Key Research and Development Program of China 2020YFA0908700National Natural Science Foundation of China 62272246
6 · The paper itself

Abstract

motivationHuman epidermal growth factor receptor 2 (HER2) status identification enables physicians to assess the prognosis risk and determine the treatment schedule for patients. In clinical practice, pathological slides serve as the gold standard, offering morphological information on cellular structure and tumoral regions. Computational analysis of pathological images has the potential to discover morphological patterns associated with HER2 molecular targets and achieve precise status prediction. However, pathological images are typically equipped with high-resolution attributes, and HER2 expression in breast cancer (BC) images often manifests the intratumoral heterogeneity.

resultsWe present a phenotype-informed weakly supervised multiple instance learning architecture (PhiHER2) for the prediction of the HER2 status from pathological images of BC. Specifically, a hierarchical prototype clustering module is designed to identify representative phenotypes across whole slide images. These phenotype embeddings are then integrated into a cross-attention module, enhancing feature interaction and aggregation on instances. This yields a phenotype-based feature space that leverages the intratumoral morphological heterogeneity for HER2 status prediction. Extensive results demonstrate that PhiHER2 captures a better WSI-level representation by the typical phenotype guidance and significantly outperforms existing methods on real-world datasets. Additionally, interpretability analyses of both phenotypes and WSIs provide explicit insights into the heterogeneity of morphological patterns associated with molecular HER2 status. AVAILABILITY AND IMPLEMENTATION: Our model is available at https://github.com/lyotvincent/PhiHER2.

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesPhenotypeComputational BiologyFemaleHumansSupervised Machine LearningERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID38940163
PMCPMC11211833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.